云南白药(000538) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥9,279,405,760.86, representing a 9.98% increase year-over-year, while the year-to-date revenue reached ¥28,362,522,490.00, up 18.52% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2021 was ¥648,867,036.60, a decrease of 63.94% year-over-year, with a year-to-date net profit of ¥2,450,534,047.88, down 42.38% compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥1,045,893,510.91 for Q3 2021, a decline of 21.70% year-over-year, while the year-to-date figure was ¥2,931,333,010.23, down 7.96%[5] - Total operating revenue for the third quarter reached ¥28.36 billion, an increase of 18.1% compared to ¥23.93 billion in the same period last year[19] - Net profit for the quarter was ¥2.45 billion, a decrease of 42.3% from ¥4.25 billion in the previous year[20] - Total comprehensive income for the third quarter was CNY 2,453,164,679.29, a decrease from CNY 4,249,556,604.22 in the same period last year[21] - The company reported a decrease in total comprehensive income attributable to the parent company, which was CNY 2,451,528,036.92, down from CNY 4,253,737,858.54[21] Cash Flow and Liquidity - The company's cash flow from operating activities for the year-to-date period was ¥6,533,923,331.40, reflecting an increase of 87.05% compared to the same period last year[5] - Cash inflow from operating activities totaled CNY 32,128,274,570.38, up from CNY 27,559,602,718.15 year-on-year[22] - Cash outflow from operating activities was CNY 25,594,351,238.98, compared to CNY 24,066,382,280.16 in the previous year[23] - Net cash flow from operating activities increased to CNY 6,533,923,331.40, compared to CNY 3,493,220,437.99 in the previous year[23] - Net cash flow from investing activities was CNY 1,431,346,301.04, a significant improvement from a negative CNY 5,321,539,763.49 in the previous year[23] - Cash and cash equivalents at the end of the period reached CNY 17,677,017,628.05, compared to CNY 7,804,731,057.00 at the end of the previous year[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥52,233,707,941.33, a decrease of 5.41% from the end of the previous year[6] - The total assets of the company decreased to ¥52.23 billion from ¥55.22 billion, a decline of 5.4% year-on-year[19] - Total liabilities decreased to ¥14.08 billion from ¥16.88 billion, a reduction of 16.5% compared to the previous year[19] - The total current assets decreased to approximately ¥46.53 billion from ¥49.26 billion year-over-year, representing a decline of 5.54%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period was 161,054, with the largest shareholder, Yunnan State-Owned Equity Operation Management Co., Ltd., holding 25.04% of shares, equating to 321,160,222 shares[12] - The top ten shareholders include Xinhua Du Industrial Group Co., Ltd. with a holding of 24.27%, which translates to 311,244,460 shares, of which 207,510,000 shares are pledged[12] - The total number of preferred shareholders with restored voting rights was not applicable, indicating no preferred shares were reported[14] Operational Changes - The company experienced a change in its board of directors, with two members resigning due to personal and work-related reasons, which will not affect the board's operational capacity[16] Expenses and Investments - Total operating costs amounted to ¥24.43 billion, up 21.5% from ¥20.16 billion year-on-year[20] - Research and development expenses increased to ¥195.58 million, compared to ¥126.79 million in the same quarter last year, reflecting a growth of 54.3%[20] - The company reported an investment income of ¥707.81 million, an increase from ¥564.56 million in the previous year, representing a growth of 25.4%[20] Other Financial Metrics - The weighted average return on equity was 1.73%, down 3.08% year-over-year[6] - Basic earnings per share decreased to CNY 1.92 from CNY 3.33 year-on-year[21] - Deferred income tax liabilities decreased significantly from ¥299.95 million to ¥55.32 million, a decline of 81.5% year-on-year[19] - The company confirmed share-based payment expenses of ¥866 million, which was not present in the previous period; excluding this impact, the net profit attributable to shareholders after deducting non-recurring gains and losses would have increased by 15.14% year-over-year[7] Financial Asset Changes - The company experienced a 90.66% decrease in notes receivable, primarily due to an increase in bill discounts during the reporting period[11] - The company reported a significant reduction in trading financial assets, which decreased to approximately ¥8.74 billion from ¥11.23 billion, a decline of 22.15%[17] - The company reported a 68.07% decrease in cash flow from financing activities, mainly due to increased cash payments for debt repayment and dividends compared to the previous period[11]